Clinical trial

AImmune - Artificial Intelligence Algorithm for Identification of Immunogenic Neoepitopes of Cancer to Predict and Boost Patient's Response to Immunotherapies.

NCT04145232

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2019-06-13

PhaseN/A

Study timeline

Study start (actual)2019-06-13Date precision: day

Registry last updated2020-08-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Neoepitopesunresolved

Neoantigensunresolved

Immunotherapyunresolved

Next Generation Sequencing (NGS)unresolved

Personalized Neoantigen Cancer Vaccineunresolved

Interventions

Collection of biopsy (FFPE), blood (PBMC) and stoolBIOLOGICAL

Sponsors & collaborators

Ardigenlead sponsor

Małopolskie Centre of Entrepreneurshipcollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04145232 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.